Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Drug And Gene Delivery Devices Market In 2029?
The market size of drug and gene delivery devices has seen substantial growth in the past few years. The current expectations are that the market will expand from $0.61 billion in 2024 to $0.67 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.0%. Several factors have contributed to this historic period of growth, including the development of healthcare infrastructure, the expansion of personalized gene therapy programs, a heightened emphasis on preventive healthcare, growing attention to rare and orphan diseases, and increased public health awareness and understanding of various treatment options.
What Growth Rate Is Forecasted for the Drug And Gene Delivery Devices Market by 2029?
In the coming years, a robust growth is anticipated in the market size of drug and gene delivery devices, which is estimated to reach $0.93 billion in 2029 with a CAGR of 8.7%. The surge forecasted for this period is due to escalating cases of chronic ailments, mushrooming demand for tailored medicine, rising comprehension and acceptance of gene therapy, preference for non-invasive and minimally invasive procedures, and the increasing trend of direct-to-patient delivery models. Key trends expected to define the forecast period incorporate progress in biotechnology and genetic engineering, advancements in drug delivery system technology, burgeoning investment in research and development, the creation of unique delivery platforms, and advancements in diagnostic technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp
Which Key Companies Are Shaping the Future of the Drug And Gene Delivery Devices Market?
Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics
Which Factors Are Driving Demand in the Drug And Gene Delivery Devices Industry?
The drug and gene delivery devices market is projected to witness significant growth due to the rising acceptance of gene therapy. This contemporary medical technique, which involves the introduction, deletion, or modification of a patient’s cellular genetic material to treat or prevent illnesses, is seeing growing demand. Its potential to eliminate genetic disorders and chronic diseases at their source has led to its popularity as it provides transformative treatments where traditional therapies fail. Drug and gene delivery devices play a crucial role in gene therapy, ensuring accurate targeting and controlled release of therapeutic genes, thereby improving treatment effectiveness. In November 2023, the National Centre for Biotechnology Information, a resource for the scientific research community in the USA, predicted that the number of patients newly treated with gene therapies would likely increase, from 16,244 in 2020 to 94,696 in 2025. As a result, the widespread adoption of gene therapy continues to fuel the expansion of the drug and gene delivery devices market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19404&type=smp
How Is the Drug And Gene Delivery Devices Market Segmented by Several Divisions?
The drug and gene delivery devicesmarket covered in this report is segmented –
1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.
What are the Emerging Market Trends Driving the Growth of the Drug And Gene Delivery Devices Industry?
Leading firms in the drug and gene delivery devices market are concentrating on creating innovative products with intricate technologies like artificial intelligence (AI) in order to secure a competitive advantage. AI in drug administration involves using AI methods and algorithms to enhance the efficiency, accuracy, and effectiveness of drug delivery systems. For example, in December 2023, Envoya Inc., a company based in the US that specializes in polymer-based nanoparticles for targeted delivery, introduced a novel gene therapy drug delivery platform. This platform merges biopolymer-nanoparticles and AI to tackle substantial constraints present in today’s gene therapy technologies such as viral vectors and lipid nanoparticles. Its aim is to conquer the shortcomings of existing gene therapy delivery methods, inhibited by safety-related concerns, low payload capacities and inadequate tissue targeting.
Access The Full Report Here:
Which Regions Are Driving Growth in the Drug And Gene Delivery Devices Market?
North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19404
This Report Delivers Insight On:
1. How big is the drug and gene delivery devices market, and how is it changing globally?
2. Who are the major companies in the drug and gene delivery devices market, and how are they performing?
3. What are the key opportunities and risks in the drug and gene delivery devices market right now?
4. Which products or customer segments are growing the most in the drug and gene delivery devices market?
5. What factors are helping or slowing down the growth of the drug and gene delivery devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model